0.05Open0.05Pre Close0 Volume365 Open Interest2.50Strike Price0.00Turnover528.33%IV417.24%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2332Delta0.5113Gamma9.86Leverage Ratio-0.0047Theta0.0000Rho2.30Eff Leverage0.0003Vega
Renovaro Stock Discussion
Globe Newswire 17-Sep-2024 9:00 AM
NEWS
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
RenovaroCube acquires 100% ownership of Cyclomics, solidifying their collaboration in cancer diagnostics.
The partnership with Oxford Nanopore and Nvidia enhances RenovaroCube's capabilities in early cancer detection and treatment monitoring.
RenovaroCube's open architecture AI platform combined with Cyclomics' 4th generation molecular technology enables accurate ...
The two companies have agreed to merge, with artificial intelligence medical technology firm GEDi becoming a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
No comment yet